Coherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) franchise to Intas Pharmaceuticals under an ...

West Auckland-based Douglas Pharmaceuticals has installed 13 AI-controlled robots. MD Jeff Douglas on whether they're a threat to the firm's 700 human staff. One of our largest high-tech exporters ...

President Donald Trump says he plans to impose tariffs on pharmaceuticals "very shortly," in what could be the next phase of his sweeping overhaul of global trade. President Donald Trump says he ...

13 analysts have expressed a variety of opinions on Jazz Pharmaceuticals JAZZ over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent ...

TAPAH: Malaysia should be prepared for the upcoming announcement from the US regarding a "major" tariff on pharmaceutical imports, says Datuk Seri Dr Dzulkefly Ahmad. The Health Minister said that ...

Shares in Britain’s two biggest drugs firms saw more than £14billion wiped off their value after Donald Trump threatened to slap tariffs on pharmaceuticals imports to the US. AstraZeneca ...

Morgan Stanley lowered the firm’s price target on Recursion Pharmaceuticals (RXRX) to $8 from $10 and keeps an Equal Weight rating on the shares. The firm updated its model based on commentary ...

MANILA, Philippines – The head of a local group of pharmaceutical firms has expressed confidence that US President Donald Trump’s new tariff policy will have minimal impact on their sector ...